FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and represents medication for prevention or reduction of pigmentation, consisting of formula (1) compound, its isomer and/or its pharmaceutically acceptable salt:
,
where R1 is non-substituted or substituted aromatic group; R2 stands for hydrogen atom, alkyl group with linear or branched chain, including 1-4 carbon atoms, or acyl group with linear or branched alkyl chain, including 1-4 carbon atoms; and R3 represents hydrogen atom or alkyl group with linear or branched chain, including 1-4 carbon atoms.
EFFECT: obtaining means for prevention or reduction of pigmentation.
10 cl, 6 tbl, 23 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR PREVENTING OR REDUCING PIGMENTATION | 2011 |
|
RU2553352C2 |
DERIVATIVES OF BENZOFURANYLALKANE CARBOXYLIC ACID OR A MIXTURE OF THEIR ISOMERS, OR SEPARATE ISOMERS, OR THEIR SALTS | 1994 |
|
RU2125564C1 |
ANTI-WRINKLE AGENTS | 2009 |
|
RU2503443C2 |
0 |
|
SU512708A3 | |
DERIVATIVES OF BENZIMIDAZOLE, PHARMACEUTICAL COMPOSITION BASED ON SAID AND THERAPEUTIC USE OF BENZIMIDAZOLE DERIVATIVES | 1996 |
|
RU2125048C1 |
0 |
|
SU516352A3 | |
COSMETIC PREPARATION | 2007 |
|
RU2463036C2 |
DERIVATIVES OF PHENYLALKYLCARBOXYLIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2169141C2 |
MELANOGENESIS INHIBITOR, WHICH CONTAINS D-PANTOTENYL ALCOHOL AND COSMETIC MEANS FOR SKIN BLEACHING THAT CONTAINS SUCH MELANOGENESIS INHIBITOR | 2015 |
|
RU2667652C2 |
DIPEPTIDES CONTAINING 2-THIOACYL GROUP AT N-TERMINAL AMINO ACID RESIDUE AS VASOPEPTIDASE INHIBITORS | 2002 |
|
RU2298559C2 |
Authors
Dates
2015-10-10—Published
2010-12-16—Filed